- 首頁
- App 分析
- AntiCoagAF
- AntiCoagAF Vs. dark GCS
AntiCoagAF 與 dark GCS 使用情況與統計
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
- Apple App Store
- 付費
- 醫療
商店排名
- -
The Glasgow Coma Scale (GCS) was developed in 1974 to assess the depth of impaired consciousness and coma following trauma. There have been a few tweaks to the GCS over the past 40 years as well as some clarification in testing.
Also includes pediatric GCS (for ages 2 and younger).
- Apple App Store
- 付費
- 醫療
商店排名
- -
AntiCoagAF與 dark GCS 比較排名
比較過去 28 天的 AntiCoagAF 排名趨勢與 dark GCS
排名
無可用數據
各國 AntiCoagAF vs. dark GCS 排名比較
比較過去 28 天的 AntiCoagAF 排名趨勢與 dark GCS
所有類別
無可用數據
醫療
使用我們的免費試用版,與所有網站進行比較
AntiCoagAF VS.
dark GCS
1月 1, 2025